In vitro studies: Xlear kills and/or deactivates SARS-CoV-2

KUALA LUMPUR, Nov 30 -- New in vitro studies led by renowned authority on respiratory diseases conclude that Xlear nasal spray is “an effective...and replicable means to deactivate SARS-CoV-2...to an undetectable amount of infectious virus.”

This is “validated by two independent sets of experiments, performed by different labs, on different viral strains...” The Virucidal studies were independently funded.

“The Virucidal Studies shed important light on the role Xlear can play in helping combat the COVID-19 pandemic,” said research team leader, Dr Gustavo Ferrer.

In vitro studies: Xlear kills and/or deactivates SARS-CoV-2: In vitro studies: Xlear kills and/or deactivates S